Dynavax Technologies Corp
NASDAQ:DVAX

Watchlist Manager
Dynavax Technologies Corp Logo
Dynavax Technologies Corp
NASDAQ:DVAX
Watchlist
Price: 10.86 USD -0.37%
Market Cap: 1.3B USD
Section:
 

Relative Value

The Relative Value of one DVAX stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.86 USD, Dynavax Technologies Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DVAX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

3.9
P/S
P/S
Price to Sales
3.9
vs History
61
vs Industry
54
Median 3Y
4.8
Median 5Y
5
Industry
7.9
Forward
3.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
2
Median 3Y
5.7
Median 5Y
5
Industry
24
Forward
-27.6
More Details
14.1
P/OCF
P/OCF
Price to OCF
14.1
vs History
44
vs Industry
7
Median 3Y
16.7
Median 5Y
13.3
Industry
21.6
More Details
37.3
P/FCFE
P/FCFE
Price to FCFE
37.3
vs History
19
vs Industry
7
Median 3Y
29.7
Median 5Y
15.9
Industry
23.7
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
79
vs Industry
31
Median 3Y
2.5
Median 5Y
2.9
Industry
3.4
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
63
vs Industry
53
Median 3Y
3.5
Median 5Y
3.6
Industry
8.3
Forward
2.6
More Details
3.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.2
vs History
71
vs Industry
54
Median 3Y
4.5
Median 5Y
4.7
Industry
10.3
More Details
69.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
69.4
vs History
14
vs Industry
0
Median 3Y
3.7
Median 5Y
4.5
Industry
6.7
Forward
35.5
More Details
85.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
85.1
vs History
4
vs Industry
4
Median 3Y
-33.4
Median 5Y
3.4
Industry
7.2
Forward
91.3
More Details
9.8
EV/OCF
EV/OCF
Enterprise Value to OCF
9.8
vs History
47
vs Industry
9
Median 3Y
12.1
Median 5Y
9.7
Industry
8.2
More Details
11
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11
vs History
44
vs Industry
7
Median 3Y
13.4
Median 5Y
10.4
Industry
6.7
More Details
3
EV/IC
EV/IC
Enterprise Value to IC
3
vs History
60
vs Industry
30
Median 3Y
3.5
Median 5Y
3.4
Industry
5.7
More Details

Multiples Across Competitors

DVAX Competitors Multiples
Dynavax Technologies Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Dynavax Technologies Corp
NASDAQ:DVAX
1.3B USD 3.9 -29.4 69.4 85.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 794 036.5 -160 618 -195 041.5 -192 815.9
US
Abbvie Inc
NYSE:ABBV
395.9B USD 6.6 168.6 16.3 23.2
US
Amgen Inc
NASDAQ:AMGN
170.8B USD 4.7 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
153B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.3B USD 9.7 30.8 22.6 23.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.7 -531.9 -579.2 -563.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.6B USD 5.5 17.2 16.3 18.5
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.8 13.3 16.5
NL
argenx SE
XBRU:ARGX
46.3B EUR 15.1 35.5 61.4 63.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
54.4B USD 16.9 1 248.3 164.2 199.1
P/E Multiple
Earnings Growth PEG
US
Dynavax Technologies Corp
NASDAQ:DVAX
Average P/E: 195.4
Negative Multiple: -29.4
50%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 618 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
9%
1.9
AU
CSL Ltd
ASX:CSL
19.8
11%
1.8
NL
argenx SE
XBRU:ARGX
35.5
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 248.3
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Dynavax Technologies Corp
NASDAQ:DVAX
Average EV/EBITDA: 43.8
69.4
347%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 041.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.6
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
11%
1.5
AU
CSL Ltd
ASX:CSL
13.3
8%
1.7
NL
argenx SE
XBRU:ARGX
61.4
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
164.2
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Dynavax Technologies Corp
NASDAQ:DVAX
Average EV/EBIT: 51
85.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 815.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
13%
1.4
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
63.1
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
199.1
N/A N/A

See Also

Summary
DVAX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DVAX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DVAX stock valuation using valuation multiples.
Wall Street Estimates
DVAX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DVAX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.